| Year |
Citation |
Score |
| 1998 |
Hileman RE, Fromm JR, Weiler JM, Linhardt RJ. Glycosaminoglycan-protein interactions: Definition of consensus sites in glycosaminoglycan binding proteins Bioessays. 20: 156-167. PMID 9631661 DOI: 10.1002/(Sici)1521-1878(199802)20:2<156::Aid-Bies8>3.0.Co;2-R |
0.641 |
|
| 1997 |
Dougher AM, Wasserstrom H, Torley L, Shridaran L, Westdock P, Hileman RE, Fromm JR, Anderberg R, Lyman S, Linhardt RJ, Kaplan J, Terman BI. Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor. Growth Factors (Chur, Switzerland). 14: 257-68. PMID 9386990 DOI: 10.3109/08977199709021524 |
0.622 |
|
| 1997 |
Fromm JR, Hileman RE, Weiler JM, Linhardt RJ. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides Archives of Biochemistry and Biophysics. 346: 252-262. PMID 9343372 DOI: 10.1006/Abbi.1997.0299 |
0.698 |
|
| 1997 |
Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, Marks RM. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate Nature Medicine. 3: 866-871. PMID 9256277 DOI: 10.1038/Nm0897-866 |
0.561 |
|
| 1997 |
Fromm JR, Hileman RE, Caldwell EE, Weiler JM, Linhardt RJ. Pattern and spacing of basic amino acids in heparin binding sites. Archives of Biochemistry and Biophysics. 343: 92-100. PMID 9210650 DOI: 10.1006/Abbi.1997.0147 |
0.658 |
|
| 1997 |
Toida T, Yoshida H, Toyoda H, Koshiishi I, Imanari T, Hileman RE, Fromm JR, Linhardt RJ. Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species. The Biochemical Journal. 499-506. PMID 9065769 DOI: 10.1042/Bj3220499 |
0.511 |
|
| 1996 |
Caldwell EE, Nadkarni VD, Fromm JR, Linhardt RJ, Weiler JM. Importance of specific amino acids in protein binding sites for heparin and heparan sulfate. The International Journal of Biochemistry & Cell Biology. 28: 203-16. PMID 8729007 DOI: 10.1016/1357-2725(95)00123-9 |
0.592 |
|
| 1996 |
Faham S, Hileman RE, Fromm JR, Linhardt RJ, Rees DC. Heparin structure and interactions with basic fibroblast growth factor. Science (New York, N.Y.). 271: 1116-20. PMID 8599088 DOI: 10.1126/Science.271.5252.1116 |
0.58 |
|
| 1996 |
Gerber SI, Fromm JR, Linhardt RJ, Herold BC. GLYCOPROTEIN C OF HERPES SIMPLEX VIRUS TYPE 1 BINDS TO SPECIFIC POLYSACCHARIDES WITHIN HEPARIN. 1016 Pediatric Research. 39: 172-172. DOI: 10.1203/00006450-199604001-01038 |
0.495 |
|
| 1995 |
Edens RE, Fromm JR, Fromm SJ, Linhardt RJ, Weiler JM. Two-dimensional affinity resolution electrophoresis demonstrates that three distinct heparin populations interact with antithrombin III. Biochemistry. 34: 2400-7. PMID 7873519 DOI: 10.1021/Bi00008A002 |
0.708 |
|
| 1995 |
Linhardt RJ, Han XJ, Fromm JR. Lectin affinity electrophoresis. Molecular Biotechnology. 3: 191-7. PMID 7552688 DOI: 10.1007/Bf02789329 |
0.51 |
|
| 1995 |
Fromm JR, Hileman RE, Caldwell EE, Weiler JM, Linhardt RJ. Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor. Archives of Biochemistry and Biophysics. 323: 279-87. PMID 7487089 DOI: 10.1006/Abbi.1995.9963 |
0.707 |
|
| 1993 |
Mach H, Volkin DB, Burke CJ, Middaugh CR, Linhardt RJ, Fromm JR, Loganathan D, Mattsson L. Nature of the interaction of heparin with acidic fibroblast growth factor. Biochemistry. 32: 5480-9. PMID 7684608 DOI: 10.1021/Bi00071A026 |
0.691 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2012 |
Fromm JR, McEarchern JA, Kennedy D, Thomas A, Shustov AR, Gopal AK. Clinical binding properties, internalization kinetics, and clinicopathologic activity of brentuximab vedotin: an antibody-drug conjugate for CD30-positive lymphoid neoplasms. Clinical Lymphoma, Myeloma & Leukemia. 12: 280-3. PMID 22542449 DOI: 10.1016/j.clml.2012.01.012 |
0.18 |
|
| 2009 |
Gopal AK, Pagel JM, Fromm JR, Wilbur S, Press OW. 131I anti-CD45 radioimmunotherapy effectively targets and treats T-cell non-Hodgkin lymphoma. Blood. 113: 5905-10. PMID 19332764 DOI: 10.1182/blood-2009-02-205476 |
0.11 |
|
| 2016 |
Zrazhevskiy P, Akilesh S, Tai W, Queitsch K, True LD, Fromm J, Wu D, Nelson P, Stamatoyannopoulos JA, Gao X. Cross-Platform DNA Encoding for Single-Cell Imaging of Gene Expression. Angewandte Chemie (International Ed. in English). PMID 27273345 DOI: 10.1002/Anie.201603945 |
0.101 |
|
| 2006 |
Fromm JR, Kussick SJ, Wood BL. Identification and purification of classical Hodgkin cells from lymph nodes by flow cytometry and flow cytometric cell sorting American Journal of Clinical Pathology. 126: 764-780. PMID 17050074 DOI: 10.1309/7371-XK6F-6P74-74XX |
0.1 |
|
| 2015 |
Salipante SJ, Adey A, Thomas A, Lee C, Liu YJ, Kumar A, Lewis AP, Wu D, Fromm JR, Shendure J. Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma. Genes, Chromosomes & Cancer. PMID 26650888 DOI: 10.1002/Gcc.22331 |
0.098 |
|
| 2014 |
Salipante SJ, Fromm JR, Shendure J, Wood BL, Wu D. Detection of minimal residual disease in NPM1-mutated acute myeloid leukemia by next-generation sequencing. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 27: 1438-46. PMID 24743218 DOI: 10.1038/Modpathol.2014.57 |
0.094 |
|
| 2017 |
Reichel JB, McCormick J, Fromm JR, Elemento O, Cesarman E, Roshal M. Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma. Journal of Visualized Experiments : Jove. PMID 28654052 DOI: 10.3791/54399 |
0.094 |
|
| 2012 |
Fromm JR, Wood BL. Strategies for immunophenotyping and purifying classical Hodgkin lymphoma cells from lymph nodes by flow cytometry and flow cytometric cell sorting Methods. 57: 368-375. PMID 22487184 DOI: 10.1016/j.ymeth.2012.03.028 |
0.089 |
|
| 2020 |
Cassaday RD, Garcia KA, Fromm JR, Percival MM, Turtle CJ, Nghiem PT, Stevenson PA, Estey EH. Phase 2 study of pembrolizumab for measurable residual disease in adults with acute lymphoblastic leukemia. Blood Advances. 4: 3239-3245. PMID 32692850 DOI: 10.1182/bloodadvances.2020002403 |
0.085 |
|
| 2019 |
Wienand K, Chapuy B, Stewart C, Dunford AJ, Wu D, Kim J, Kamburov A, Wood TR, Cader FZ, Ducar MD, Thorner AR, Nag A, Heubeck AT, Buonopane MJ, Redd RA, ... ... Fromm JR, et al. Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion. Blood Advances. 3: 4065-4080. PMID 31816062 DOI: 10.1182/Bloodadvances.2019001012 |
0.082 |
|
| 2015 |
Soma L, Wu D, Chen X, Edlefsen K, Fromm JR, Wood B. Apparent CD19 expression by natural killer cells: a potential confounder for minimal residual disease detection by flow cytometry in B lymphoblastic leukemia. Cytometry. Part B, Clinical Cytometry. 88: 145-7. PMID 25091590 DOI: 10.1002/cyto.b.21179 |
0.079 |
|
| 2012 |
Wu D, Sherwood A, Fromm JR, Winter SS, Dunsmore KP, Loh ML, Greisman HA, Sabath DE, Wood BL, Robins H. High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia. Science Translational Medicine. 4: 134ra63. PMID 22593176 DOI: 10.1126/Scitranslmed.3003656 |
0.078 |
|
| 2014 |
Soma L, Wu D, Chen X, Edlefsen K, Fromm JR, Wood B. Apparent CD19 expression by natural killer cells: A potential confounder for minimal residual disease detection by flow cytometry in B lymphoblastic leukemia. Cytometry. Part B, Clinical Cytometry. PMID 25046149 DOI: 10.1002/cytob.21179 |
0.078 |
|
| 2009 |
Salipante SJ, Mealiffe ME, Wechsler J, Krem MM, Liu Y, Namkoong S, Bhagat G, Kirchhoff T, Offit K, Lynch H, Wiernik PH, Roshal M, McMaster ML, Tucker M, Fromm JR, et al. Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells Proceedings of the National Academy of Sciences of the United States of America. 106: 14920-14925. PMID 19706467 DOI: 10.1073/pnas.0904231106 |
0.072 |
|
| 2024 |
Wang H, Koob T, Fromm JR, Gopal A, Carter D, Lieber A. CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells. Cancer Biology & Therapy. 25: 2314322. PMID 38361357 DOI: 10.1080/15384047.2024.2314322 |
0.072 |
|
| 2018 |
Zhou Y, Moon A, Hoyle E, Fromm JR, Chen X, Soma L, Salipante SJ, Wood BL, Wu D. Pattern associated leukemia immunophenotypes and measurable disease detection in acute myeloid leukemia or myelodysplastic syndrome with mutated NPM1. Cytometry. Part B, Clinical Cytometry. PMID 30417521 DOI: 10.1002/cyto.b.21744 |
0.072 |
|
| 2016 |
Cherian S, Miller V, McCullouch V, Dougherty K, Fromm JR, Wood BL. A novel flow cytometric assay for detection of residual disease in patients with B-lymphoblastic leukemia/lymphoma post anti-CD19 therapy. Cytometry. Part B, Clinical Cytometry. PMID 27598971 DOI: 10.1002/cyto.b.21482 |
0.071 |
|
| 2011 |
Edlefsen KL, Greisman HA, Yi HS, Mantei KM, Fromm JR. Early lymph node involvement by mantle cell lymphoma limited to the germinal center: Report of a case with a novel "follicular in situ" growth pattern American Journal of Clinical Pathology. 136: 276-281. PMID 21757601 DOI: 10.1309/AJCP6KFFGTC8PLVR |
0.07 |
|
| 2014 |
Fromm JR, Wood BL. A six-color flow cytometry assay for immunophenotyping classical Hodgkin lymphoma in lymph nodes American Journal of Clinical Pathology. 141: 388-396. PMID 24515767 DOI: 10.1309/AJCP0Q1SVOXBHMAM |
0.068 |
|
| 2023 |
Ally F, Gajzer D, Fromm JR. A Review of the Flow Cytometric Findings in Classic Hodgkin Lymphoma, Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte-Rich Large B Cell Lymphoma. Clinics in Laboratory Medicine. 43: 427-444. PMID 37481321 DOI: 10.1016/j.cll.2023.04.011 |
0.067 |
|
| 2011 |
Roshal M, Wood BL, Fromm JR. Flow cytometric detection of the classical hodgkin lymphoma: clinical and research applications. Advances in Hematology. 2011: 387034. PMID 21127714 DOI: 10.1155/2011/387034 |
0.067 |
|
| 2013 |
Chen X, Soma LA, Fromm JR. Targeted therapy for Hodgkin lymphoma and systemic anaplastic large cell lymphoma: focus on brentuximab vedotin. Oncotargets and Therapy. 7: 45-56. PMID 24379682 DOI: 10.2147/OTT.S39107 |
0.067 |
|
| 2017 |
Potts DA, Fromm JR, Gopal AK, Cassaday RD. Spontaneous Remission of an Untreated, MYC and BCL2 Coexpressing, High-Grade B-Cell Lymphoma: A Case Report and Literature Review. Case Reports in Hematology. 2017: 2676254. PMID 28321348 DOI: 10.1155/2017/2676254 |
0.064 |
|
| 2016 |
Fromm JR, Thomas A, Wood BL. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. The American Journal of Pathology. PMID 27998726 DOI: 10.1016/j.ajpath.2016.10.007 |
0.064 |
|
| 2013 |
Wu D, Wood BL, Fromm JR. Flow cytometry for non-Hodgkin and classical Hodgkin lymphoma. Methods in Molecular Biology (Clifton, N.J.). 971: 27-47. PMID 23296956 DOI: 10.1007/978-1-62703-269-8_2 |
0.061 |
|
| 2010 |
Roshal M, Fromm JR, Winter S, Dunsmore K, Wood BL. Immaturity associated antigens are lost during induction for T cell lymphoblastic leukemia: Implications for minimal residual disease detection Cytometry Part B - Clinical Cytometry. 78: 139-146. PMID 20155852 DOI: 10.1002/cyto.b.20511 |
0.061 |
|
| 2009 |
Fromm JR, Thomas A, Wood BL. Flow cytometry can diagnose classical hodgkin lymphoma in lymph nodes with high sensitivity and specificity American Journal of Clinical Pathology. 131: 322-332. PMID 19228638 DOI: 10.1309/AJCPW3UN9DYLDSPB |
0.059 |
|
| 2015 |
Ng DP, Wu D, Wood BL, Fromm JR. Computer-aided detection of rare tumor populations in flow cytometry: an example with classic Hodgkin lymphoma. American Journal of Clinical Pathology. 144: 517-24. PMID 26276783 DOI: 10.1309/AJCPY8E2LYHCGUFP |
0.059 |
|
| 2011 |
Jokinen CH, Fromm JR, Argenyi ZB, Olerud J, Wood BL, Greisman HA. Flow cytometric evaluation of skin biopsies for mycosis fungoides American Journal of Dermatopathology. 33: 483-491. PMID 21552102 DOI: 10.1097/DAD.0b013e31820595da |
0.059 |
|
| 2019 |
Glynn E, Soma L, Wu D, Wood BL, Fromm JR. Flow Cytometry for Non-Hodgkin and Hodgkin Lymphomas. Methods in Molecular Biology (Clifton, N.J.). 1956: 35-60. PMID 30779029 DOI: 10.1007/978-1-4939-9151-8_2 |
0.058 |
|
| 2011 |
Fromm JR. Flow cytometric analysis of CD123 is useful for immunophenotyping classical Hodgkin lymphoma. Cytometry. Part B, Clinical Cytometry. 80: 91-9. PMID 20809502 DOI: 10.1002/cyto.b.20561 |
0.056 |
|
| 2021 |
Wang A, Song Z, Zheng G, Nicolazzi C, Fromm JR, Shehu E, Srinivasan S, Chen X, Zhu C, Chiron Blondel M, Adrian FJ. Evaluation of Preclinical Activity of Isatuximab in Patients with Acute Lymphoblastic Leukemia. Molecular Cancer Therapeutics. PMID 34376579 DOI: 10.1158/1535-7163.MCT-21-0058 |
0.055 |
|
| 2019 |
Glynn E, Fromm JR. Immunophenotypic Characterization and Purification of Neoplastic Cells from Lymph Nodes Involved by T-Cell/Histiocyte-rich Large B-cell Lymphoma by Flow Cytometry and Flow Cytometric Cell Sorting. Cytometry. Part B, Clinical Cytometry. PMID 31254446 DOI: 10.1002/cyto.b.21834 |
0.055 |
|
| 2010 |
Wu D, Wood BL, Dorer R, Fromm JR. "Double-hit" mature B-cell lymphomas show a common immunophenotype by flow cytometry that includes decreased CD20 expression American Journal of Clinical Pathology. 134: 258-265. PMID 20660329 DOI: 10.1309/AJCP7YLDTJPLCE5F |
0.053 |
|
| 2016 |
Blau CA, Ramirez AB, Blau S, Pritchard CC, Dorschner MO, Schmechel SC, Martins TJ, Mahen EM, Burton KA, Komashko VM, Radenbaugh AJ, Dougherty K, Thomas A, Miller CP, Annis J, ... Fromm JR, et al. A Distributed Network for Intensive Longitudinal Monitoring in Metastatic Triple-Negative Breast Cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 14: 8-17. PMID 26733551 DOI: 10.6004/Jnccn.2016.0003 |
0.051 |
|
| 2018 |
Cader FZ, Schackmann RCJ, Hu X, Wienand K, Redd R, Chapuy B, Ouyang J, Paul N, Gjini E, Lipschitz M, Armand P, Wu D, Fromm JR, Neuberg D, Liu XS, et al. Mass cytometry of Hodgkin lymphoma reveals a CD4 exhausted T-effector and T-regulatory cell rich microenvironment. Blood. PMID 29880615 DOI: 10.1182/blood-2018-04-843714 |
0.049 |
|
| 2017 |
Ravanpay AC, Fromm JR, Edlefsen KL, Martin P, Chesnut R. The first report of human primary thoracic spine mast cell sarcoma: a case report. Clinical Neuropathology. PMID 28992848 DOI: 10.5414/Np301038 |
0.046 |
|
| 2022 |
Pan C, Wu QV, Voutsinas J, Houlton JJ, Barber B, Futran N, Laramore GE, Liao JJ, Parvathaneni U, Martins RG, Fromm JR, Rodriguez CP. Neutrophil to lymphocyte ratio and peripheral blood biomarkers correlate with survival outcomes but not response among head and neck and salivary cancer treated with pembrolizumab and vorinostat. Head & Neck. PMID 36412064 DOI: 10.1002/hed.27252 |
0.046 |
|
| 2018 |
Cowan AJ, Stevenson PA, Libby EN, Becker PS, Coffey DG, Green DJ, Hyun TS, Fromm JR, Gopal AK, Holmberg LA. Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance Therapy. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29481870 DOI: 10.1016/j.bbmt.2018.02.017 |
0.045 |
|
| 2023 |
Cenariu D, Rus I, Bergthorsson JT, Grewal R, Cenariu M, Greiff V, Tigu AB, Dima D, Selicean C, Petrushev B, Zdrenghea M, Fromm J, Aanei CM, Tomuleasa C. Flow Cytometry of CD5-Positive Hairy Cell Leukemia. Molecular Diagnosis & Therapy. PMID 37291380 DOI: 10.1007/s40291-023-00658-x |
0.043 |
|
| 2019 |
Fromm JR, Edlefsen KL, Cherian S, Wood BL, Soma L, Wu D. Flow cytometric features of incidental indolent T lymphoblastic proliferations. Cytometry. Part B, Clinical Cytometry. PMID 31571375 DOI: 10.1002/cyto.b.21845 |
0.043 |
|
| 2019 |
Kim A, Stevenson P, Cassaday RD, Soma L, Fromm JR, Gopal A, Smith SD, Till B, Lynch R, Ujjani C, Shadman M, Warren EH, Menon M, Russell K, Tseng YD. Impact of double/triple hit pathology on rates and durability of RT response among patients with relapsed/refractory large B-cell lymphoma. Practical Radiation Oncology. PMID 31585205 DOI: 10.1016/j.prro.2019.09.013 |
0.043 |
|
| 2023 |
Pan C, Wu QV, Voutsinas J, Houlton JJ, Barber B, Rizvi ZH, Marchiano E, Futran N, Laramore GE, Liao JJ, Parvathaneni U, Martins RG, Fromm JR, Rodriguez CP. Peripheral lymphocytes and lactate dehydrogenase correlate with response and survival in head and neck cancers treated with immune checkpoint inhibitors. Cancer Medicine. PMID 36806947 DOI: 10.1002/cam4.5697 |
0.041 |
|
| 2019 |
Pillai V, Muralidharan K, Meng W, Bagashev A, Oldridge DA, Rosenthal J, Van Arnam J, Melenhorst JJ, Mohan D, DiNofia AM, Luo M, Cherian S, Fromm JR, Wertheim G, Thomas-Tikhonenko A, et al. CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy. Blood Advances. 3: 3539-3549. PMID 31738832 DOI: 10.1182/Bloodadvances.2019000692 |
0.041 |
|
| 2008 |
Stetsenko GY, McFarlane R, Kalus A, Olerud J, Cherian S, Fromm J, George E, Argenyi Z. CD4+/CD56+ hematodermic neoplasm: report of a rare variant with a T-cell receptor gene rearrangement. Journal of Cutaneous Pathology. 35: 579-84. PMID 18005171 DOI: 10.1111/j.1600-0560.2007.00845.x |
0.041 |
|
| 2018 |
Grewal RK, Chetty M, Abayomi EA, Tomuleasa C, Fromm JR. Use of flow cytometry in the phenotypic diagnosis of hodgkin's lymphoma. Cytometry. Part B, Clinical Cytometry. PMID 30350336 DOI: 10.1002/cyto.b.21724 |
0.04 |
|
| 2023 |
Chapman S, Almiski M, Marko D, Sekiguchi D, Dawson AJ, Keijzer R, Fromm J, Israels SJ. Skin Lesions as a Presenting Feature of Dimorphic T-Lymphoblastic Leukemia in an Adolescent Male. Journal of Pediatric Hematology/Oncology. 45: 209-212. PMID 37027217 DOI: 10.1097/MPH.0000000000002659 |
0.04 |
|
| 2021 |
Simonson PD, Wu Y, Wu D, Fromm JR, Lee AY. De Novo Identification and Visualization of Important Cell Populations for Classic Hodgkin Lymphoma Using Flow Cytometry and Machine Learning. American Journal of Clinical Pathology. PMID 34175918 DOI: 10.1093/ajcp/aqab076 |
0.04 |
|
| 2023 |
Ho C, Gopal AK, Till BG, Shadman M, Lynch RC, Cowan AJ, Wu QV, Voutsinas J, Rasmussen HA, Blue K, Ujjani CS, Cassaday RD, Fromm JR, Fang M, Smith SD. Pembrolizumab With R-CHOP in Previously Untreated DLBCL: Sustained, High Efficacy, and Safety With Long-Term Follow-Up. Clinical Lymphoma, Myeloma & Leukemia. PMID 37926672 DOI: 10.1016/j.clml.2023.10.002 |
0.039 |
|
| 2015 |
Wu D, Thomas A, Fromm JR. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma. Cytometry. Part B, Clinical Cytometry. PMID 26084540 DOI: 10.1002/cyto.b.21261 |
0.039 |
|
| 2022 |
Fromm JR, Tang C, Naresh KN. Predictors of risk of relapse in classic Hodgkin lymphoma. Journal of Clinical Pathology. PMID 36241372 DOI: 10.1136/jcp-2022-208552 |
0.039 |
|
| 2015 |
Cherian S, McCullouch V, Miller V, Dougherty K, Fromm JR, Wood BL. Expression of CD2 and CD25 on mast cell populations can be seen outside the setting of systemic mastocytosis. Cytometry. Part B, Clinical Cytometry. PMID 26525770 DOI: 10.1002/cyto.b.21336 |
0.037 |
|
| 2017 |
Ketterl TG, Wu D, Fromm JR, Soma L, Dahlberg AE, Wood BL, Tarlock K. Donor derived T-cell large granular lymphocyte leukemia after cord blood transplant for pediatric T-cell lymphoblastic leukemia. Bone Marrow Transplantation. PMID 29269802 DOI: 10.1038/s41409-017-0037-9 |
0.036 |
|
| 2015 |
Cowan AJ, Stevenson PA, Cassaday RD, Graf SA, Fromm JR, Wu D, Holmberg LA, Till BG, Chauncey TR, Smith SD, Philip M, Orozco JJ, Shustov AR, Green D, Libby EN, et al. Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26348890 DOI: 10.1016/J.Bbmt.2015.08.035 |
0.036 |
|
| 2005 |
Kussick SJ, Fromm JR, Rossini A, Li Y, Chang A, Norwood TH, Wood BL. Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia American Journal of Clinical Pathology. 124: 170-181. PMID 16040286 DOI: 10.1309/6PBP-78G4-FBA1-FDG6 |
0.036 |
|
| 2021 |
Martig DS, Fromm JR. A comparison and review of the flow cytometric findings in classic Hodgkin lymphoma, nodular lymphocyte predominant Hodgkin lymphoma, T cell/histiocyte rich large B cell lymphoma, and primary mediastinal large B cell lymphoma. Cytometry. Part B, Clinical Cytometry. PMID 34878224 DOI: 10.1002/cyto.b.22045 |
0.035 |
|
| 2014 |
Wu D, Allen CT, Fromm JR. Flow cytometry of ALK-negative anaplastic large cell lymphoma of breast implant-associated effusion and capsular tissue. Cytometry. Part B, Clinical Cytometry. PMID 24976005 DOI: 10.1002/cytob.21178 |
0.035 |
|
| 2020 |
Smith SD, Till BG, Shadman MS, Lynch RC, Cowan AJ, Wu QW, Voutsinas J, Rasmussen HA, Blue K, Ujjani CS, Shustov A, Cassaday RD, Fromm JR, Gopal AK. Pembrolizumab with R-CHOP in previously untreated diffuse large B-cell lymphoma: potential for biomarker driven therapy. British Journal of Haematology. PMID 32030732 DOI: 10.1111/bjh.16494 |
0.035 |
|
| 2021 |
Simonson PD, Ren X, Fromm JR. Creating Virtual Hematoxylin and Eosin Images using Samples Imaged on a Commercial CODEX Platform. Journal of Pathology Informatics. 12: 52. PMID 35070481 DOI: 10.4103/jpi.jpi_114_20 |
0.035 |
|
| 2022 |
Graf SA, Lynch R, Ujjani CS, Gooley TA, Rasmussen H, Coffey DG, Cowan AJ, Smith SD, Shadman M, Warren EH, Libby E, Greninger AL, Fromm JR, Gopal AK. Efficacy, Safety, and Molecular Response Predictors of Oral Ixazomib and Short-Course Rituximab in Untreated iNHL. Blood Advances. PMID 36385536 DOI: 10.1182/bloodadvances.2022008628 |
0.034 |
|
| 2023 |
Torabi A, Fromm JR, Naresh KN. MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte-predominant Hodgkin lymphoma. Ejhaem. 4: 517-519. PMID 37206275 DOI: 10.1002/jha2.690 |
0.032 |
|
| 2015 |
Wu D, Allen CT, Fromm JR. Flow cytometry of ALK-negative anaplastic large cell lymphoma of breast implant-associated effusion and capsular tissue. Cytometry. Part B, Clinical Cytometry. 88: 58-63. PMID 25044944 DOI: 10.1002/cyto.b.21178 |
0.031 |
|
| 2017 |
Cherian S, Fromm JR. Evaluation of Primary Mediastinal Large B cell Lymphoma by Flow Cytometry. Cytometry. Part B, Clinical Cytometry. PMID 28732145 DOI: 10.1002/cyto.b.21544 |
0.031 |
|
| 2022 |
Greenbaum AM, Fromm JR, Gopal AK, Houghton AM. Diffuse large B-cell lymphoma (DLBCL) is infiltrated with activated CD8 T-cells despite immune checkpoint signaling. Blood Research. PMID 35551108 DOI: 10.5045/br.2022.2021145 |
0.03 |
|
| 2019 |
Rodriguez CP, Wu Q, Voutsinas J, Fromm JR, Jiang X, Pillarisetty VG, Lee SM, Santana-Davila R, Goulart B, Baik CS, Chow LQM, Eaton K, Martins R. A phase II trial of pembrolizumab and vorinostat in recurrent metastatic head and neck squamous cell carcinomas and salivary gland cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31796519 DOI: 10.1158/1078-0432.CCR-19-2214 |
0.03 |
|
| 2020 |
Castillo JJ, Libby EN, Ansell SM, Palomba ML, Meid K, Flynn CA, Leventoff C, Hergott CB, Sewastianik T, Morgan EA, Carrasco R, Fromm JR, Yang G, Hunter Z, Treon SP. Multicenter phase 2 study of daratumumab monotherapy in patients with previously treated Waldenström macroglobulinemia. Blood Advances. 4: 5089-5092. PMID 33085756 DOI: 10.1182/bloodadvances.2020003087 |
0.029 |
|
| 2022 |
Chen X, Fromm JR, Naresh KN. "Blasts" in myeloid neoplasms - how do we define blasts and how do we incorporate them into diagnostic schema moving forward? Leukemia. 36: 327-332. PMID 35042955 DOI: 10.1038/s41375-021-01498-6 |
0.027 |
|
| 2010 |
Fromm JR, Thomas A, Wood BL. Increased expression of T cell antigens on T cells in classical Hodgkin lymphoma Cytometry Part B - Clinical Cytometry. 78: 387-388. PMID 20533387 DOI: 10.1002/cyto.b.20535 |
0.026 |
|
| 2024 |
Schwarz LW, Love JE, Naresh KN, Shameli A, Fromm JR. Use of CD32, CD44 and CD71 to differentiate follicular lymphoma and diffuse large B-cell lymphoma subtypes by flow cytometry. Journal of Clinical Pathology. PMID 38336474 DOI: 10.1136/jcp-2023-209366 |
0.022 |
|
| 2015 |
Fromm JR, Tagliente DJ, Shaver AC, Neppalli V, Craig FE. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry. Part B, Clinical Cytometry. PMID 25906760 DOI: 10.1002/cyto.b.21238 |
0.021 |
|
| 2017 |
Brady AK, Fromm JR, Kapnadak SG. An Unusual Cause of Pulmonary Nodules After Stem Cell Transplantation. Chest. 151: e29-e34. PMID 28183501 DOI: 10.1016/j.chest.2016.11.022 |
0.021 |
|
| 2019 |
Godwin CD, Fromm JR, Othus M, Sandmaier BM, Mielcarek MB, Wood BL, Appelbaum FR, Storb R, Walter RB. Pre-transplant bone marrow monocytic myeloid-derived suppressor cell frequency is not associated with outcome after allogeneic hematopoietic cell transplantation for acute myeloid leukemia in remission. Bone Marrow Transplantation. PMID 30804488 DOI: 10.1038/S41409-019-0481-9 |
0.019 |
|
| 2021 |
Soma LA, Smith SD, Reddy P, Edlefsen KL, Wu D, Cherian S, Chen X, Zhou Y, Reddi D, Fromm JR. Clinicopathologic Findings in Patients With Initial Diagnosis of Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) in Colorectal Mucosa. American Journal of Clinical Pathology. PMID 34463316 DOI: 10.1093/ajcp/aqab089 |
0.018 |
|
| 2017 |
Ferrufino-Schmidt MC, Medeiros LJ, Liu H, Clemens MW, Hunt KK, Laurent C, Lofts J, Amin MB, Ming Chai S, Morine A, Di Napoli A, Dogan A, Parkash V, Bhagat G, Tritz D, ... ... Fromm JR, et al. Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma. The American Journal of Surgical Pathology. PMID 29194092 DOI: 10.1097/PAS.0000000000000985 |
0.017 |
|
| 2013 |
Wu D, Wood BL, Dorer R, Fromm JR. Utility of flow cytometry for immunophenotyping double-hit lymphomas. Cytometry. Part B, Clinical Cytometry. 84: 398. PMID 24038887 DOI: 10.1002/cyto.b.21117 |
0.016 |
|
| 2013 |
Fromm JR, Wood BL. Immunophenotyping of classical Hodgkin's lymphoma by flow cytometry Annals of Hematology. 92: 569. PMID 23100163 DOI: 10.1007/s00277-012-1608-x |
0.016 |
|
| 2021 |
Lynch RC, Cassaday RD, Smith SD, Fromm JR, Cowan AJ, Warren EH, Shadman MS, Shustov A, Till BG, Ujjani CS, Libby EN, Philip M, Coye H, Martino CN, Bhark SL, et al. Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study. The Lancet. Haematology. 8: e562-e571. PMID 34329577 DOI: 10.1016/S2352-3026(21)00170-8 |
0.011 |
|
| 2018 |
Poston JN, Fromm JR, Rasmussen HA, Shustov AR, Libby EN, Smith SD, Gooley T, Gopal AK. A pilot study of weekly brentuximab vedotin in patients with CD30+ malignancies resistant to brentuximab vedotin every 3 weeks. British Journal of Haematology. PMID 30592026 DOI: 10.1111/bjh.15742 |
0.01 |
|
| 2011 |
Fromm JR, Sabath DE, Wood BL. Diagnostic usefulness of flow cytometry for immunophenotyping classical hodgkin lymphoma American Journal of Clinical Pathology. 136: 157-158. PMID 21685044 DOI: 10.1309/AJCP45LUYQSOKRVE |
0.01 |
|
| Hide low-probability matches. |